These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19307154)

  • 1. The dopaminergic neurons of the A11 system in RLS autopsy brains appear normal.
    Earley CJ; Allen RP; Connor JR; Ferrucci L; Troncoso J
    Sleep Med; 2009 Dec; 10(10):1155-7. PubMed ID: 19307154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.
    Connor JR; Wang XS; Allen RP; Beard JL; Wiesinger JA; Felt BT; Earley CJ
    Brain; 2009 Sep; 132(Pt 9):2403-12. PubMed ID: 19467991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless legs syndrome and periodic limb movements.
    Vetrugno R; Provini F; Montagna P
    Rev Neurol Dis; 2006; 3(2):61-70. PubMed ID: 16820753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome.
    Connor JR; Boyer PJ; Menzies SL; Dellinger B; Allen RP; Ondo WG; Earley CJ
    Neurology; 2003 Aug; 61(3):304-9. PubMed ID: 12913188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective.
    Clemens S; Rye D; Hochman S
    Neurology; 2006 Jul; 67(1):125-30. PubMed ID: 16832090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.
    Earley CJ; Uhl GR; Clemens S; Ferré S
    Sleep Med; 2017 Mar; 31():71-77. PubMed ID: 27539027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three Types of A11 Neurons Project to the Rat Spinal Cord.
    Ozawa H; Yamaguchi T; Hamaguchi S; Yamaguchi S; Ueda S
    Neurochem Res; 2017 Aug; 42(8):2142-2153. PubMed ID: 28303496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of A11 neurons projecting to the spinal cord of mice.
    Koblinger K; Füzesi T; Ejdrygiewicz J; Krajacic A; Bains JS; Whelan PJ
    PLoS One; 2014; 9(10):e109636. PubMed ID: 25343491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical colocalization of hypothalamic progestin receptors and tyrosine hydroxylase in steroid-treated monkeys.
    Kohama SG; Freesh F; Bethea CL
    Endocrinology; 1992 Jul; 131(1):509-17. PubMed ID: 1351839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology of restless legs syndrome].
    Miyamoto M; Miyamoto T; Iwanami M; Suzuki K; Hirata K
    Brain Nerve; 2009 May; 61(5):523-32. PubMed ID: 19514512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projections of diencephalic dopamine neurons into the spinal cord in mice.
    Qu S; Ondo WG; Zhang X; Xie WJ; Pan TH; Le WD
    Exp Brain Res; 2006 Jan; 168(1-2):152-6. PubMed ID: 16044299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome.
    Qu S; Le W; Zhang X; Xie W; Zhang A; Ondo WG
    J Neuropathol Exp Neurol; 2007 May; 66(5):383-8. PubMed ID: 17483695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological concepts of restless legs syndrome.
    Paulus W; Dowling P; Rijsman R; Stiasny-Kolster K; Trenkwalder C; de Weerd A
    Mov Disord; 2007 Jul; 22(10):1451-1456. PubMed ID: 17516488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible sites of therapeutic action in restless legs syndrome: focus on dopamine and α2δ ligands.
    Thorpe AJ; Clair A; Hochman S; Clemens S
    Eur Neurol; 2011; 66(1):18-29. PubMed ID: 21709418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson's disease during chronic dopaminergic therapy.
    Marchesi E; Negrotti A; Angelini M; Goldoni M; Abrignani G; Calzetti S
    J Neurol; 2016 Mar; 263(3):441-7. PubMed ID: 26566909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of supraspinal motor circuitry reveals a distributed network underlying Restless Legs Syndrome (RLS)-like movements in the rat.
    Guo CN; Yang WJ; Zhan SQ; Yang XF; Chen MC; Fuller PM; Lu J
    Sci Rep; 2017 Aug; 7(1):9905. PubMed ID: 28852150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.
    Cervenka S; Pålhagen SE; Comley RA; Panagiotidis G; Cselényi Z; Matthews JC; Lai RY; Halldin C; Farde L
    Brain; 2006 Aug; 129(Pt 8):2017-28. PubMed ID: 16816393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caenorhabditis elegans and its applicability to studies on restless legs syndrome.
    Chen P; Ijomone OM; Lee KH; Aschner M
    Adv Pharmacol; 2019; 84():147-174. PubMed ID: 31229169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    O'Callaghan JP; Miller DB; Reinhard JF
    Brain Res; 1990 Jun; 521(1-2):73-80. PubMed ID: 1976416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of iron in restless legs syndrome.
    Allen RP; Earley CJ
    Mov Disord; 2007; 22 Suppl 18():S440-8. PubMed ID: 17566122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.